IN8BIO, INC. Shareholders' Equity
IN8BIO, INC. (INAB) had Shareholders' Equity of $18.36 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $18.36M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $22.78M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $27.56M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $13.19M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $18.36M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $22.78M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $27.56M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $13.19M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $15.24M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $13.88M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $14.48M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $8.59M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $13.62M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $17.53M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $24.94M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $17.76M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $21.80M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $16.79M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $22.73M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $29.56M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $26.57M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $32.84M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | -$38.18M 10-K · filed 2024-03-14 | $38.18M 10-K · filed 2022-03-17 |
| 2021-09-30 | $43.04M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$21.24M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | -$18.58M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | -$16.58M 10-K · filed 2023-03-30 | |
| 2020-09-30 | -$14.88M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$13.57M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | -$10.71M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | -$9.24M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |